SARS-CoV-2 Spike S1 Protein Antibody (CR3022) - Azide and BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-26919
Key Product Details
Species Reactivity
Applications
Label
Antibody Source
Format
Concentration
Product Specifications
Immunogen
Clonality
Host
Isotype
Description
Scientific Data Images for SARS-CoV-2 Spike S1 Protein Antibody (CR3022) - Azide and BSA Free
Western Blot: SARS-CoV-2 Spike S1 Protein Antibody (CR3022) - Azide and BSA Free [NBP3-26919] -
Western Blot: SARS-CoV-2 Spike S1 Protein Antibody (CR3022) - Azide and BSA Free [NBP3-26919] - Coomassie blue staining non-reduced and reduced SDS-PAGE analysisELISA: SARS-CoV-2 Spike S1 Protein Antibody (CR3022) - Azide and BSA Free [NBP3-26919] -
ELISA: SARS-CoV-2 Spike S1 Protein Antibody (CR3022) - Azide and BSA Free [NBP3-26919] - Sandwich ELISA for SARS-CoV-2 Matched Pair Spike S1 Antibodies. Antibodies: SARS-CoV-2 Spike Antibodies, NBP3-07065 and NBP3-26919. A sandwich ELISA was performed using SARS-CoV-2 Spike S1 antibody (NBP3-07065, 2ug/ml) as capture antibody, the Spike S1 recombinant protein as the binding protein, and the anti-SARS-CoV-2 Spike S1 protein antibody (NBP3-26919, 1ug/ml) as the detection antibody. Secondary: Mouse anti-human IgG HRP conjugate at 1:10000 dilution. Detection range is from 0.03 ng to 300 ng. EC50 = 1.58 ng.Applications for SARS-CoV-2 Spike S1 Protein Antibody (CR3022) - Azide and BSA Free
ELISA
Formulation, Preparation, and Storage
Purification
Formulation
Format
Preservative
Concentration
Shipping
Stability & Storage
Background: Spike S1 Subunit
Spike S1 subunit refers to the N-terminal part of the coronavirus Spike protein. The S1 subunit contains an N-terminal domain in addition to the much-studied receptor binding domain (RBD). Spatially, the S1 subunit represents the most membrane-distal portion of the spike protein. For SARS-CoV-2, this subunit, specifically the RBD domain, is responsible for binding to ACE-2 on the surface of human cells and initiating viral entry. Because this interaction is so important for viral entry into host cells, the RBD domain has been the focus of therapeutic and vaccine development for COVID-19. The N-terminal domain of the S1 subunit may also be involved in receptor binding independent of ACE-2. Current research is underway to better understand this domain as it may unlock new therapeutic strategies to fight SARS-CoV-2.
Long Name
Alternate Names
Additional Spike S1 Subunit Products
Product Documents for SARS-CoV-2 Spike S1 Protein Antibody (CR3022) - Azide and BSA Free
Product Specific Notices for SARS-CoV-2 Spike S1 Protein Antibody (CR3022) - Azide and BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.